Emisphere, a biopharmaceutical company, has developed a broad-based proprietary drug delivery platform called the Eligen® Technology. Emisphere's Eligen® Technology improves the body's ability to absorb select molecules. Emisphere's carriers provide a demonstrated safe method of chaperoning molecules without affecting their biological benefit. Many of these molecules are currently delivered by injection, such as salmon calcitonin; in certain cases, ...
read moreEmisphere is conducting early research using its Eligen® Technology and GLP-1, a potential treatment for Type 2 ...
read moreVitamin B12 is necessary for the formation and maturation of red blood cells and for the synthesis of DNA. It is also ...
read more


sending
enquiry |